BIO-key International, Inc.
BKYI
$0.71
-$0.03-3.98%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.55M | 1.70M | 1.61M | 1.46M | 2.14M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.55M | 1.70M | 1.61M | 1.46M | 2.14M |
| Cost of Revenue | 358.00K | 464.20K | 279.50K | 262.40K | 465.10K |
| Gross Profit | 1.19M | 1.23M | 1.33M | 1.20M | 1.68M |
| SG&A Expenses | 1.40M | 1.68M | 1.37M | 1.85M | 1.61M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.44M | 2.78M | 2.25M | 2.73M | 2.73M |
| Operating Income | -892.20K | -1.08M | -640.60K | -1.27M | -580.40K |
| Income Before Tax | -964.80K | -1.17M | -736.50K | -1.41M | -739.00K |
| Income Tax Expenses | -- | -- | -- | -23.00K | -- |
| Earnings from Continuing Operations | -964.80K | -1.17M | -736.50K | -1.38M | -739.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -964.80K | -1.17M | -736.50K | -1.38M | -739.00K |
| EBIT | -892.20K | -1.08M | -640.60K | -1.27M | -580.40K |
| EBITDA | -814.60K | -983.40K | -542.60K | -1.17M | -480.00K |
| EPS Basic | -0.15 | -0.20 | -0.16 | -0.46 | -0.39 |
| Normalized Basic EPS | -0.09 | -0.13 | -0.10 | -0.29 | -0.24 |
| EPS Diluted | -0.15 | -0.20 | -0.16 | -0.46 | -0.39 |
| Normalized Diluted EPS | -0.09 | -0.13 | -0.10 | -0.29 | -0.24 |
| Average Basic Shares Outstanding | 6.59M | 5.82M | 4.70M | 3.03M | 1.89M |
| Average Diluted Shares Outstanding | 6.59M | 5.82M | 4.70M | 3.03M | 1.89M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |